|
RNF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.000600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.252960E-01 |
| Normal-vs-Stage2 |
4.290100E-02 |
| Normal-vs-Stage3 |
3.550600E-01 |
| Normal-vs-Stage4 |
2.801200E-01 |
| Stage1-vs-Stage2 |
3.076400E-01 |
| Stage1-vs-Stage3 |
9.557600E-01 |
| Stage1-vs-Stage4 |
1.598050E-01 |
| Stage2-vs-Stage3 |
3.915000E-01 |
| Stage2-vs-Stage4 |
2.955800E-02 |
| Stage3-vs-Stage4 |
1.733370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.856100E-02 |
| Normal-vs-AfricanAmerican |
3.947900E-02 |
| Normal-vs-Asian |
7.868800E-01 |
| Caucasian-vs-AfricanAmerican |
4.592200E-01 |
| Caucasian-vs-Asian |
8.608200E-01 |
| AfricanAmerican-vs-Asian |
6.757000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.624230E-02 |
| Normal-vs-Female |
6.270300E-02 |
| Male-vs-Female |
8.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.099000E-01 |
| Normal-vs-Extreme_Weight |
1.507380E-01 |
| Normal-vs-Obese |
8.631700E-02 |
| Normal-vs-Extreme_Obese |
5.235000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.581000E-01 |
| Normal_Weight-vs-Obese |
2.284400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.144800E-01 |
| Extreme_Weight-vs-Obese |
6.497000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.990200E-01 |
| Obese-vs-Extreme_Obese |
8.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.365150E-01 |
| Normal-vs-Age(41-60Yrs) |
7.394800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.767200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.338800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.297400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.145600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.398000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.256400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.614000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.768600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.412620E-04 |
| Normal-VS-Type2 PRCC |
9.384000E-01 |
| Normal-VS-KIRP CIMP |
7.696500E-02 |
| Normal-VS-Unclassified PRCC |
5.795900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.623800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.764800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.749400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.450220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.290300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.478200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.442000E-01 |
| Normal-vs-N1 |
5.689200E-01 |
| Normal-vs-N2 |
9.615000E-03 |
| N0-vs-N1 |
6.604800E-01 |
| N0-vs-N2 |
1.583020E-01 |
| N1-vs-N2 |
1.866190E-01 |
|
|
